Perspective Therapeutics Inc (CATX)
Cost of Revenue
$1.90M
TTM · Period ending: · USD
CATX Cost of Revenue
Latest reported$1.90Mperiod ending
Latest reported$1.90Mperiod ending
CATX TTM Cost of Revenue ($0.00 → $1.90M)
TTM cost of revenue
High-resolution chart · PNG
CATX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,901,000 | |
| 2,634,000 | |
| 2,177,000 | |
| 2,177,000 | |
| 1,402,000 | |
| 1,025,000 | |
| 565,000 | |
| 565,000 | |
| 2,405,000 | |
| 7,419,000 | |
| 8,786,000 | |
| 10,218,000 | |
| 9,681,000 | |
| 5,890,000 | |
| 5,783,000 | |
| 5,947,000 | |
| 6,179,000 | |
| 5,964,000 | |
| 5,733,000 | |
| 5,329,000 | |
| 4,932,000 | |
| 4,776,000 | |
| 4,712,000 | |
| 4,615,000 | |
| 4,556,000 | |
| 4,393,000 | |
| 4,264,000 | |
| 4,308,000 | |
| 4,267,000 | |
| 4,388,000 | |
| 4,307,000 | |
| 4,173,000 | |
| 4,081,000 | |
| 3,787,000 | |
| 3,812,000 | |
| 3,836,000 | |
| 3,923,000 | |
| 4,218,765 | |
| 4,362,162 | |
| 4,495,259 | |
| 4,640,122 | |
| 4,608,139 | |
| 4,578,654 | |
| 4,520,106 | |
| 4,439,146 | |
| 4,389,043 | |
| 4,369,544 | |
| 4,385,309 | |
| 4,415,629 | |
| 4,428,693 | |
| 4,410,854 | |
| 4,425,623 | |
| 4,375,057 | |
| 4,354,216 | |
| 4,401,793 | |
| 4,297,467 | |
| 4,367,885 | |
| 4,089,739 | |
| 4,029,856 | |
| 4,117,104 | |
| 4,081,556 | |
| 4,431,075 | |
| 4,528,537 | |
| 4,511,725 | |
| 4,560,287 | |
| 4,658,454 | |
| 4,858,768 | |
| 5,482,800 | |
| 5,771,147 | |
| 5,903,551 | |
| 6,235,488 | |
| 6,753,058 | |
| 7,310,124 | |
| 7,590,390 | |
| 7,364,387 | |
| 6,509,986 | |
| 5,792,629 | |
| 5,519,742 | |
| 4,854,221 | |
| 4,383,101 | |
| 3,815,122 | |
| 3,148,063 | |
| 2,876,606 | |
| 1,960,332 | |
| 1,240,166 | |
| 520,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |